Human herpesvirus 6 infection of the gastroduodenal mucosa

Clinical Infectious Diseases

Volumn 46, Issue 3, 2008, Pages 434-439

  Halme, Leena ^a   Arola, Johanna ^a   Höckerstedt, Krister ^a   Lautenschlager, Irmeli ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; BILIARY TRACT DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DUODENUM MUCOSA; DYSPEPSIA; FROZEN SECTION; GASTRITIS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MUCOSA; GASTROSCOPY; GRAFT RECIPIENT; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UPPER GASTROINTESTINAL TRACT; VIRUS DETECTION;

ADULT; CYTOMEGALOVIRUS; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; GASTRIC MUCOSA; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LIVER TRANSPLANTATION; ROSEOLOVIRUS INFECTIONS;

EID: 39349100873     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/525264     Document Type: Article

References (23)

1. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthema subitum. Lancet 1988; 1:1065-7.
2. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features and therapy. Clin Microbiol Rev 2005; 18:217-45.
3. Ljungman P, Singh N. Human herpesvirus-6 in solid organ and stem cell transplant recipients. J Clin Virol 2006; 37(Suppl 1):S87-91.
4. Lautenschlager I, Linnavuori K, Höckerstedt K. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 2000; 69:2561-6.
5. Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 infection after liver transplantation: documentation of pathogenicity. Transplantation 1997; 64:674-8.
6. Lautenschlager I, Höckerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998; 26:702-7.
7. Schmidt CA, Wilbron F, Weiss K, et al. A prospective study of human herpesvirus type 6 detected by polymerase chain reaction after liver transplantation. Transplantation 1996; 61:662-4.
8. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolf P, Obert G. Longitudinal study of human herpes virus 6 infection in organ transplant recipients. Clin Infect Dis 1996; 22:171-3.
9. Razonable R, Paya C. The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation. Liver Transpl 2002;8:651-8.
10. Singh N, Paterson DL. Encephalitis caused by human herpesvirus-6 infection in liver transplant recipients: relevance of a novel neurotropic virus. Transplantation 2000; 69:2474-9.
11. Hentrich M, Oruzio D, Jäger G, et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 2005; 128:66-72.
12. Amo K, Tanaka-Taya K, Inagi R, et al. Human herpesvirus 6B infection of the large intestine of patients with diarrhea. Clin Infect Dis 2003; 36:120-3.
13. The TH, van der Berg AP, Harmsen MC, van der Bij W, van Son WJ. The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis 1995; 99:25-9.
14. Halme L, Höckerstedt K, Lautenschlager I. Cytomegalovirus infection and development of biliary complications after liver transplantation. Transplantation 2003; 75:1853-8.
15. Gesser R, Koo S. Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract. J Virol 1997; 71:4103-6.
16. Toljamo K, Niemelä S, Karttunen T, et al. The role of herpes simplex and Helicobacter pylori infection in the etiology of persistent or recurrent gastric erosions. Dig Dis Sci 2002; 47:818-22.
17. Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993; 119:924-35.
18. Sinzer C, Grefte A, Plachter B, et al. Fibroblasts, epithelial cells, endothelial cells and smooth muscle are major targets of human cytomegalovirus in lung and gastrointestinal tissues. J Gen Virol 1995; 76:741-50.
19. Mendez JC, Dockrell DH, Espy MJ, et al. Human beta-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 2001; 183:179-84.
20. DesJardin JA, Gibbons L, Cho E, et al. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 1998; 178:1783-6.
21. Humar A, Kumar D, Caliendo AM, et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 2002; 73:599-604.
22. Rogers J, Rohal S, Carrigan DR, et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications and outcome. Transplantation 2000; 69:2566-74.
23. Dockrell DH, Mendez JC, Jones M, et al. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation 1999; 67:399-403.